We predict that the deletion of TRPC1 will exert a more profound impact on cellular activity compared to knockouts of TRPC heteromers, especially in neurological conditions such as Huntington’s disease and Parkinson’s disease. The gene discussed is TRPC1; the disease is Huntington disease.